Latest Breaking News On - தோல் நோய் - Page 15 : comparemela.com

Why the stock of Alkem Labs is a good ‘Buy’ The stock is suitable for long-term investors, given multiple positives and reasonable valuation Alkem Laboratories, the fifth largest pharma company in India, is a dominant player in acute therapy areas with well-established brands. The company is ranked number one market share in terms of revenue in anti-infectives. It also has the third largest market share each in gastro-intestinal and pain and analgesics therapies. Over the years, Alkem Labs has held on to or improved its rankings in these areas. In the chronic segment too, which covers neurology, dermatology, cardiology and anti-diabetics, Alkem Labs, despite smaller presence, has managed to up its market share.

Glenmark pharmaceuticalsAlkem laboratoriesAlkem labsPharma companyPharma stockAnti infectivesChronic segmentAnti diabeticsAlembic pharmaceuticalsIpca laboratoriesTorrent pharmaceuticalsக்ளேண்மர்க் மருந்துகள்அல்கெம் ஆய்வகங்கள்பார்மா நிறுவனம்பார்மா ஸ்டாக்இரைப்பை குடல்